Characterization of Novel POLG Mutations in Mitochondrial Encephalomyopathy: Pathogenic Validation and Comprehensive Genetic Profiling
Brain and Behavior · 2025
DOI: 10.1002/brb3.71045 ↗Kurz gefasst
Fallbericht in der Zeitschrift Brain and Behavior, 2025. Verfasst von Fanjing Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: DNA Polymerase gamma, Mitochondrial Encephalomyopathies. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Introduction/Aims Mitochondrial encephalomyopathies are multisystem disorders caused by defects in mitochondrial DNA (mtDNA) or nuclear DNA (nDNA). Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis (SANDO) syndrome is a rare manifestation, often associated with POLG mutations. This study identifies a novel POLG mutation in a SANDO patient, validates its pathogenicity, and analyzes the molecular genetics of 61 reported POLG‐SANDO cases.
Methods
After obtaining informed consent, the proband underwent neurological examination, electromyography, muscle/nerve biopsies (histochemical/ultrastructural analyses), and genetic testing (whole‐exome sequencing, mtDNA analysis). Pathogenicity of identified POLG variants was assessed in Cas9‐mediated primary neuronal models expressing mutant proteins by measuring reactive oxygen species (ROS) levels and mtDNA copy number (qRT‐PCR, ND1/APP ratio). Literature searches (PubMed, CNKI, Wanfang, and ClinVar) identified reported POLG mutations and clinical features in SANDO.
Results
Clinical and biopsy findings confirmed SANDO syndrome. Genetic analysis revealed compound heterozygous POLG mutations: a novel c.3297G>C (p.W1099C) and a known c.1774C>T (p.L592F). Neurons expressing either mutant exhibited elevated ROS levels ( p < 0.05) and reduced mtDNA copy number compared with controls. Literature synthesis identified over 30 SANDO‐associated POLG mutations, with p.A467T (31.2%) and p.W748S (22.1%) being the most frequent. The mean age of onset was 31.6 years.
Conclusions
We identify a novel pathogenic POLG variant (p.W1099C) causing mitochondrial dysfunction via impaired mtDNA maintenance, expanding the SANDO genetic spectrum. Functional studies confirmed both mutations induce mitochondrial dysfunction (elevated ROS and decreased mtDNA Copy Number), validating their pathogenicity. The compiled mutation profile aids diagnosis of this phenotypically heterogeneous, frequently misdiagnosed disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
- Department of Neurology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology and Institute of Translational Medicine for Brain Critical Diseases, Nanjing University, Nanjing, China.
ORCID-Profile: Fanjing Zhou
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Zhou, F., Chen, J., Zhang, T., Niu, F., Hu, J., Xu, Y., & Zhang, M. (2025). Characterization of Novel POLG Mutations in Mitochondrial Encephalomyopathy: Pathogenic Validation and Comprehensive Genetic Profiling. Brain and Behavior. https://doi.org/10.1002/brb3.71045
Vancouver
Zhou F, Chen J, Zhang T, Niu F, Hu J, Xu Y, et al. Characterization of Novel POLG Mutations in Mitochondrial Encephalomyopathy: Pathogenic Validation and Comprehensive Genetic Profiling. Brain and Behavior. 2025. doi:10.1002/brb3.71045
BibTeX
@article{Zhou2025,
author = {Zhou, Fanjing and Chen, Jiang and Zhang, Tingzheng and Niu, Fengnan and Hu, Jinglong and Xu, Yun and Zhang, Meijuan},
title = {Characterization of Novel POLG Mutations in Mitochondrial Encephalomyopathy: Pathogenic Validation and Comprehensive Genetic Profiling},
journal = {Brain and Behavior},
year = {2025},
doi = {10.1002/brb3.71045}
}
EUVIMED